Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stehle

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|December 20, 1993
Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparinsJ Harenberg, M Siegele, C E Dempfle, et al.
Journal of Neurosurgery|March 6, 1999
Direct convective macromolecule deliveryG Stehle, D L Heene, A Wunder, et al.
International Journal of Cancer|May 8, 2001
Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivoA M Burger, G Hartung, G Stehle, et al.
Thrombosis and Haemostasis|June 30, 1989
Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteersJ Harenberg, C Giese, C E Dempfle, et al.
American Journal of Obstetrics and Gynecology|September 15, 1977
Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage formsT J Roseman, G D Gutknecht, R G Stehle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assayJ Harenberg, B Haaf, C E Dempfle, et al.
Thrombosis Research|October 1, 1983
Disposition of human fibrinopeptide A in normal and nephrectomized rabbitsJ Harenberg, G Stehle, S Waibel, et al.
Thrombosis Research|October 1, 1992
Heparin Study in Internal Medicine (HESIM): design and preliminary resultsJ Harenberg, P Roebruck, G Stehle, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosisJ Harenberg, G Stehle, M Blauth, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effectsJ Harenberg, G Stehle, C E Dempfle, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|December 20, 1993
Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparinsJ Harenberg, M Siegele, C E Dempfle, et al.
Journal of Neurosurgery|March 6, 1999
Direct convective macromolecule deliveryG Stehle, D L Heene, A Wunder, et al.
International Journal of Cancer|May 8, 2001
Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivoA M Burger, G Hartung, G Stehle, et al.
Thrombosis and Haemostasis|June 30, 1989
Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteersJ Harenberg, C Giese, C E Dempfle, et al.
American Journal of Obstetrics and Gynecology|September 15, 1977
Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage formsT J Roseman, G D Gutknecht, R G Stehle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assayJ Harenberg, B Haaf, C E Dempfle, et al.
Thrombosis Research|October 1, 1983
Disposition of human fibrinopeptide A in normal and nephrectomized rabbitsJ Harenberg, G Stehle, S Waibel, et al.
Thrombosis Research|October 1, 1992
Heparin Study in Internal Medicine (HESIM): design and preliminary resultsJ Harenberg, P Roebruck, G Stehle, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosisJ Harenberg, G Stehle, M Blauth, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effectsJ Harenberg, G Stehle, C E Dempfle, et al.
Pageof 6